diphenylcyclopropenone has been researched along with Alopecia in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (18.75) | 18.7374 |
| 1990's | 5 (31.25) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 5 (31.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rujitharanawong, C; Thuangtong, R; Triwongwaranat, D; Varothai, S | 1 |
| Kim, BJ; Lee, S; Lee, WS; Lee, YB | 1 |
| Cho, S; Huh, CH; Kim, MW; Kwon, O; Lee, JS; Park, HS; Shin, JW | 1 |
| Wolff, H | 1 |
| Bergfeld, WF; Chiang, KS; Mesinkovska, NA; Piliang, MP | 1 |
| Crichlow, S; Warin, AP | 1 |
| Happle, R; Hausen, BM; Wiesner-Menzel, L | 1 |
| Abbott, F; Ho, V; Shapiro, J; Tan, J; Tron, V | 1 |
| Happle, R; Hoffmann, R | 1 |
| Shapiro, J | 1 |
| Arase, S; Nameda, Y; Skrebova, N; Takiwaki, H | 1 |
| Brahams, D | 1 |
| Berth-Jones, J; Hutchinson, PE | 1 |
| Duhra, P; Foulds, IS | 1 |
| Monk, B | 1 |
| Ashworth, J; Mackie, RM; Tuyp, E | 1 |
2 review(s) available for diphenylcyclopropenone and Alopecia
| Article | Year |
|---|---|
Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata: A Systematic Review and Meta-analysis.
Topics: Adjuvants, Immunologic; Alopecia; Alopecia Areata; Cyclobutanes; Cyclopropanes; Hair; Humans; Immunotherapy; Recurrence | 2018 |
Topical immunotherapy in alopecia areata. What, how, and why?
Topics: Administration, Topical; Alopecia; Cyclopropanes; Humans; Immunotherapy | 1996 |
4 trial(s) available for diphenylcyclopropenone and Alopecia
| Article | Year |
|---|---|
Multi-Concentration Level Patch Test Guided Diphenyl Cyclopropenone (DPCP) Treatment in Alopecia Totalis or Alopecia Universalis.
Topics: Adolescent; Adult; Aged; Alopecia; Cyclopropanes; Female; Humans; Male; Middle Aged; Patch Tests; Time; Treatment Outcome; Young Adult | 2017 |
Diphencyprone in the treatment of alopecia areata.
Topics: Adolescent; Adult; Alopecia; Alopecia Areata; Chemical Phenomena; Chemistry; Cyclopropanes; Dermatitis, Contact; Female; Hair; Humans; Male; Middle Aged; Time Factors | 1983 |
Treatment of chronic severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation.
Topics: Administration, Cutaneous; Adult; Aged; Alopecia; Antibodies, Monoclonal; Antigens, CD; CD4 Antigens; CD8 Antigens; Cell Adhesion Molecules; Chronic Disease; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunophenotyping; Intercellular Adhesion Molecule-1; Keratinocytes; Langerhans Cells; Male; Middle Aged; Minoxidil; Severity of Illness Index; T-Lymphocyte Subsets | 1993 |
Allergic and irritant contact dermatitis compared in the treatment of alopecia totalis and universalis. A comparison of the value of topical diphencyprone and tretinoin gel.
Topics: Administration, Topical; Adolescent; Adult; Aged; Alopecia; Child; Child, Preschool; Cyclopropanes; Dermatitis, Contact; Female; Humans; Male; Middle Aged; Tretinoin | 1989 |
10 other study(ies) available for diphenylcyclopropenone and Alopecia
| Article | Year |
|---|---|
Comparison of the Treatment Outcome of Oral Tofacitinib with Other Conventional Therapies in Refractory Alopecia Totalis and Universalis: A Retrospective Study.
Topics: Administration, Oral; Adolescent; Adult; Alopecia; Cyclopropanes; Cyclosporine; Female; Humans; Immunosuppressive Agents; Janus Kinase Inhibitors; Male; Middle Aged; Piperidines; Pyrimidines; Pyrroles; Retrospective Studies; Steroids; Time Factors; Treatment Outcome; Young Adult | 2019 |
[Drug treatment of alopecia].
Topics: Administration, Topical; Adrenal Cortex Hormones; Alopecia; Anti-Bacterial Agents; Cyclopropanes; Evidence-Based Medicine; Finasteride; Humans; Minoxidil; Treatment Outcome | 2015 |
Clinical Efficacy of Diphenylcyclopropenone in Alopecia Areata: Retrospective Data Analysis of 50 Patients.
Topics: Administration, Cutaneous; Adolescent; Adult; Alopecia; Alopecia Areata; Child; Cyclopropanes; Dermatologic Agents; Female; Hair; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Severity of Illness Index; Thyroid Diseases; Time Factors; Treatment Outcome; Young Adult | 2015 |
Allergic contact dermatitis from dyes in wigs following diphencyprone treatment.
Topics: Adult; Alopecia; Coloring Agents; Cyclopropanes; Dermatitis, Allergic Contact; Dermatologic Agents; Female; Humans; Risk Factors; Scalp Dermatoses | 2004 |
Practical management of alopecia areata and outlook for the future.
Topics: Alopecia; Cyclopropanes; Dermatology; Humans; Immunotherapy; PUVA Therapy | 1999 |
Severe dermographism after topical therapy with diphenylcyclopropenone for alopecia universalis.
Topics: Administration, Topical; Adult; Alopecia; Cyclopropanes; Dermatitis, Allergic Contact; Humans; Laser-Doppler Flowmetry; Male; Prognosis; Scalp Dermatoses; Severity of Illness Index; Urticaria | 2000 |
Expert witnesses and experimental treatment: the extent of the duty to warn of risks when using experimental treatment.
Topics: Alopecia; Cyclopropanes; Duty to Warn; Expert Testimony; Female; Human Experimentation; Humans; Informed Consent; Risk Factors; United Kingdom; Vitiligo | 2001 |
Treatment of alopecia totalis with a combination of inosine pranobex and diphencyprone compared to each treatment alone.
Topics: Adolescent; Adult; Aged; Alopecia; Cyclopropanes; Dermatitis, Contact; Drug Therapy, Combination; Female; Hair; Humans; Inosine Pranobex; Male; Middle Aged | 1991 |
Persistent vitiligo induced by diphencyprone.
Topics: Adult; Alopecia; Cyclopropanes; Humans; Male; Vitiligo | 1990 |
Induction of hair growth in alopecia totalis with diphencyprone sensitization.
Topics: Adult; Alopecia; Alopecia Areata; Child; Cyclopropanes; Female; Hair; Humans; Male | 1989 |